EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Crushed posaconazole delayed-release tablets via enteric feeding tube administration: practical considerations for clinicians

Nirjan Bhattarai, Dan Ilges iD, Ryan W Stevens iD

Journal of Antimicrobial Chemotherapy · 03.06.2026 · 81 (7)

DOI: 10.1093/jac/dkag201 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 08.06.2026. Verfasst von Nirjan Bhattarai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Antifungal Agents, Triazoles, Delayed-Action Preparations, Tablets. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Posaconazole delayed-release (DR) tablets are labelled as ‘do not crush’ medications. Despite this designation, emerging research demonstrates successful attainment of therapeutic serum concentrations, suggesting that they may be pharmacokinetically superior to the immediate-release (IR) suspension when given via enteric feeding tube (EFT). While crushed posaconazole DR tablets may be better suited than the IR suspension to attain therapeutic serum concentrations, several practical factors must be considered, including lack of dose equivalency between crushed DR tablets for EFT administration and DR tablets swallowed whole and the risk of EFT occlusion. This article summarizes the current evidence on posaconazole serum concentrations with crushed DR tablets administered via EFT, explores risks of this practice and provides mitigation strategies for application in the clinical setting, including proposed dosing and administration practices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsTriazolesDelayed-Action PreparationsTabletsEnteral NutritionHumans

Substanzen

posaconazoleAntifungal AgentsTriazolesDelayed-Action PreparationsTablets

Autor:innen und Institutionen

  • Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  • Department of Pharmacy, Mayo Clinic Arizona, Phoenix, AZ, USA.

ORCID-Profile: Dan Ilges, Ryan W Stevens

Zitieren

APA

Bhattarai, N., Ilges, D., & Stevens, R. W. (2026). Crushed posaconazole delayed-release tablets via enteric feeding tube administration: practical considerations for clinicians. Journal of Antimicrobial Chemotherapy, 81(7). https://doi.org/10.1093/jac/dkag201

Vancouver

Bhattarai N, Ilges D, Stevens RW. Crushed posaconazole delayed-release tablets via enteric feeding tube administration: practical considerations for clinicians. Journal of Antimicrobial Chemotherapy. 2026;81(7). doi:10.1093/jac/dkag201

BibTeX
@article{Bhattarai2026,
  author = {Bhattarai, Nirjan and Ilges, Dan and Stevens, Ryan W},
  title = {Crushed posaconazole delayed-release tablets via enteric feeding tube administration: practical considerations for clinicians},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {7},
  doi = {10.1093/jac/dkag201}
}
Kostenlos starten →